Clinicians are unaware of the risk of recurrent VTE in children, resulting in not only an increase in the overall recurrence of VTE, but the associated healthcare costs. Results from recent clinical trials examining therapeutic options to prevent recurrent VTE in pediatric patients are relatively unknown among healthcare professionals. The management of the recurrent risk of VTE often includes a transition of care of anticoagulation therapy from the acute to post-acute setting, which is relatively new to many pediatric healthcare professionals. This program discusses how pediatric healthcare professionals can assess and reduce the risk of venous thromboembolism in children.